2+ day, 14+ hour ago   (200+ words) Charter Communications short interest was 33.62% of the float on August 31st, according to new data we received from Benzinga. Short interest totaled 14,985,512 shares, which was a decrease of -34.8% from August 14th. It is estimated that it would take 4.79 days for short sellers…...

3+ day, 13+ hour ago   (299+ words) High Roller Technologies will present at the H.C. Wainwright conference in New York City on September 14, 2026. The presentation will take place on September 14, 2026, at 4:30 PM ET. The conference will be held at Lotte New York Palace, New York City. Investors can…...

3+ day, 6+ hour ago   (210+ words) Richtech Robotics will showcase AI humanoid robot DEX and Titan 440 mobile robot at IMTS 2026, demonstrating coordinated industrial automation. Richtech Robotics is demonstrating its AI-enabled humanoid robot DEX and Titan 440 autonomous mobile robot working together at Booth #236380. DEX and Titan 440 coordinate…...

3+ day, 16+ hour ago   (257+ words) TG Therapeutics' CEO will speak at the H.C. Wainwright Conference on September 14, 2026, with a live webcast available. TG Therapeutics will participate in the H.C. Wainwright 28th Annual Global Investment Conference from September 14-16, 2026. Michael S. Weiss, the Chairman and CEO of TG Therapeutics, will participate…...

3+ day, 11+ hour ago   (321+ words) Cullinan Therapeutics announces interim Phase 3 trial results of zipalertinib for NSCLC, to be discussed in a virtual event. The trial studies zipalertinib plus chemotherapy for EGFR exon 20 insertion mutation-positive NSCLC. The results will be presented on September 13, 2026, at the Presidential…...

3+ day, 15+ hour ago   (282+ words) HUB Cyber Security announced a 1-for-25 reverse share split effective September 11, 2026, to improve share trading price compliance. The reverse share split will take effect at 11:59 p.m. Eastern Time on September 11, 2026. Every 25 issued Ordinary Shares will convert into one Ordinary Share, affecting…...

3+ day, 14+ hour ago   (300+ words) IMUNON partners with NCI's CTEP to explore new uses for IMNN-001 immunotherapy in clinical trials. The collaboration aims to evaluate IMNN-001 for new cancer indications and combination regimens. IMNN-001 is a DNA-based IL-12 immunotherapy developed by IMUNON for treating advanced ovarian…...

3+ day, 16+ hour ago   (250+ words) Inuvo, Inc. will present at the H.C. Wainwright Global Investment Conference from September 14-16, 2026, in New York City. Inuvo, Inc. will be participating in the H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 2026. Management is scheduled to present on Monday, September 14, 2026, at 1:00 PM…...

4+ day, 7+ hour ago   (247+ words) InterDigital announces a quarterly cash dividend increase from $0.70 to $0.75 per share, payable October 28, 2026. InterDigital has increased its quarterly cash dividend from $0.70 to $0.75 per share, effective in Q4 2026. The new dividend of $0.75 per share will be payable on October 28, 2026, to shareholders of…...

4+ day, 5+ hour ago   (249+ words) Initial results from RESTORE-PV show DISC-3405 improves symptoms in polycythemia vera by increasing hepcidin and reducing phlebotomy needs. The RESTORE-PV trial showed that DISC-3405 increased hepcidin, lowered serum iron, and reduced phlebotomy in PV patients. DISC-3405 is a monoclonal antibody…...